Amorfix and OGI to develop Alzheimer's blood test
Guest ContributorFebruary 14, 2006
Amorfix Life Sciences Inc is teaming with the Ontario Genomics Institute (OGI) to develop a blood test for Alzheimer's disease. OGI will initially invest $100,000 to accelerate Amorfix's EP-AD project, potentially followed by another $100,000 in two tranches in return for 50,000 in warrants convertible to shares....
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.